Confidentiality Slim, Punctuality Prime In Sunscreen TEA Draft Guidances
This article was originally published in The Tan Sheet
Executive Summary
CDER’s draft guidances on formatting TEAs, withdrawals of applications and requesting an advisory committee review arrive along with its draft on safety and effectiveness data to determine whether OTC sunscreen active ingredients should be added to the monograph.
You may also be interested in...
Sunscreen Guidances Underscore FDA Standards Aren’t Changing
CDER has published guidances, required by the 2014 Sunscreen Innovation Act, on FDA’s process for advisory committees to consider firms’ sunscreen ingredient proposals and on withdrawing pending proposals being considered by the agency.
Sunscreen Guidances Underscore FDA Standards Aren’t Changing
CDER has published guidances, required by the 2014 Sunscreen Innovation Act, on FDA’s process for advisory committees to consider firms’ sunscreen ingredient proposals and on withdrawing pending proposals being considered by the agency.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.